10 20 30 40 50 60 70 80 2GXX - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER 09-MAY-06 2GXX
TITLE MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO TITLE 2 BIS[5-(2- IMIDAZOLINYL)-2-BENZIMIDAZOLYL]METHANE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- COMPND 3 3'; COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: MODEL BUILT
KEYWDS MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE KEYWDS 2 DERIVATIVE
EXPDTA THEORETICAL MODEL
AUTHOR SAHER A SHAIKH
REVDAT 1 17-OCT-06 2GXX 0
JRNL AUTH SAHER A SHAIKH,B JAYARAM JRNL TITL A SWIFT ALL-ATOM ENERGY BASED COMPUTATIONAL JRNL TITL 2 PROTOCOL TO PREDICT DNA-DRUG BINDING AFFINITY AND JRNL TITL 3 DELTATM JRNL REF TO BE PUBLISHED 2006 JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 8 REMARK 3 AUTHORS : D.A. CASE, T.A. DARDEN, T.E. CHEATHAM, III, REMARK 3 C.L. SIMMERLING, J. WANG, R.E. DUKE, R. LUO, REMARK 3 K.M. MERZ, B. WANG, D.A. PEARLMAN, M. CROWLEY, REMARK 3 S. BROZELL, V. TSUI, H. GOHLKE, J. MONGAN, V. REMARK 3 HORNAK, G. CUI, P. BEROZA, C. SCHAFMEISTER, J.W. REMARK 3 CALDWELL, W.S. ROSS, AND P.A. KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2GXX COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 09-MAY-2006. REMARK 100 THE RCSB ID CODE IS RCSB037684.
REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: MODEL BUILDING FOLLOWED BY OPTIMIZATION BY ENERGY REMARK 220 MINIMIZATION AND MOLECULAR DYNAMICS SIMULATIONS WITH REMARK 220 EXPLICIT SOLVENT AND COUNTERIONS. THIS THEORETICAL MODEL REMARK 220 ENTRY WAS NOT ANNOTATED AND NOT VALIDATED BY THE WWPDB REMARK 220 STAFF AND THEREFORE MAY NOT CONFORM TO THE PDB FORMAT.
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GXC RELATED DB: PDB REMARK 900 RELATED ID: 2GXJ RELATED DB: PDB REMARK 900 RELATED ID: 2GXV RELATED DB: PDB REMARK 900 RELATED ID: 2GXW RELATED DB: PDB
SEQRES 1 A 12 C G C G A A T T C G C G SEQRES 1 B 12 C G C G A A T T C G C G
HET 3SB 25 47
FORMUL 3 3SB
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000